News

from the fight to #SaveIndiePharmacy

New York Times’ The Middlemen series

PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing Scheme with Express Scripts, Inc.
Policy & Medicine St. Paul Corner Drug (SPCD) Policy & Medicine St. Paul Corner Drug (SPCD)

PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing Scheme with Express Scripts, Inc.

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and Blue Shield Plans, was found guilty of engaging in horizontal price-fixing in collaboration with Express Scripts, Inc. (ESI), a competitor owned by Cigna.

Read More
Congress Can't Wait—Reform Pharmacy Benefit Managers and Deliver Lower-Cost Drugs for Patients | Opinion
Newsweek St. Paul Corner Drug (SPCD) Newsweek St. Paul Corner Drug (SPCD)

Congress Can't Wait—Reform Pharmacy Benefit Managers and Deliver Lower-Cost Drugs for Patients | Opinion

As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As members of Congress begin negotiating the continuing resolution set for March, they can make prescriptions more affordable for Americans and eliminate government waste in the American health care system by prioritizing pharmacy benefit manager (PBM) reform.

Read More
Key Facts on Health Coverage of Immigrants
KFF St. Paul Corner Drug (SPCD) KFF St. Paul Corner Drug (SPCD)

Key Facts on Health Coverage of Immigrants

As of 2023, half (50%) of likely undocumented immigrant adults and one in five (18%) lawfully present immigrant adults reported being uninsured compared to less than one in ten naturalized citizen (6%) and U.S.-born citizen (8%) adults.

Read More
UnitedHealth Group ordered to pay $165 million over deceptive sales practices
The Minnesota Star Tribune St. Paul Corner Drug (SPCD) The Minnesota Star Tribune St. Paul Corner Drug (SPCD)

UnitedHealth Group ordered to pay $165 million over deceptive sales practices

UnitedHealth Group will appeal an order to pay $165 million in penalties and restitution after a judge found a business acquired by the Eden Prairie-based insurer more than five years ago used deceptive practices to sell benefits that supplement traditional health insurance in Massachusetts.

Read More